Top Markets
#1 Black Phoenix Black Phoenix +355.71%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +57.01%
#4 Gold Park Gold Park +55.15%
#5 Acurast Acurast +28.90%
#6 BasedHype BasedHype +28.38%
#7 Cryptopia Cryptopia +22.67%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.42%
#9 Avantis Avantis +16.65%
#10 HOME HOME +15.01%
Coin of the day
Black Phoenix Black Phoenix
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
WayPoint Biomedical Holdings, Inc. WayPoint Biomedical Holdings, Inc.

WayPoint Biomedical Holdings, Inc.

WYPH
Kedudukan dalam Saham #41548
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary,... WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests for cocaine and marijuana detection. The company also develops and commercializes test kits for detection against possible explosive devices, biowarfare/bioterrorism agents, and the detection of weapons of mass destruction. In addition, it provides Frontline Explosive Test Kit for the detection of explosive residues. The company offers its products to the over-the-counter diagnostic self-testing, the diagnostic point of care, and the homeland security and defense markets. WayPoint Biomedical Holdings was founded in 2004 and is based in Huntington Beach, California.
Harga Saham
$0.0005
Disegerakkan terakhir: 2026-08-12
Modal Pasaran
$16.62K
Perubahan (1 hari)
-64.29%
Perubahan (1 tahun)
400.00%
Negara
US
Perdagangan WayPoint Biomedical Holdings, Inc. (WYPH)

Kategori

Industrials
Nisbah P/E bagi WayPoint Biomedical Holdings, Inc. (WYPH)
Nisbah P/E pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini WayPoint Biomedical Holdings, Inc., nisbah P/E semasa (TTM) ialah 0. Pada akhir 2026, syarikat mempunyai nisbah P/E sebanyak 0.
Sejarah nisbah P/E bagi WayPoint Biomedical Holdings, Inc. dari 2026 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
Cintas Corporation Cintas Corporation
Cintas Corporation
CTAS.US
 41.17 -
US
Thomson Reuters Corporation Thomson Reuters Corporation
Thomson Reuters Corporation
TRI.TO
 - -
CA
Copart, Inc. Copart, Inc.
Copart, Inc.
CPRT.US
 17.98 -
US
Brambles Limited Brambles Limited
Brambles Limited
BXB.AX
 20.24 -
AU
Aramark Aramark
Aramark
ARMK.US
 41.89 -
US
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.